Gynecological

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(AstraZeneca) D0816L00003 / LIGHTNon-Randomized, Open-Label Phase II Study to Assess Olaparib Tablets as a Treatment for Subjects with Different HRD Tumor Status and with Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That Have Received at Least 2 Prior
Lines of Chemotherapy
Helpman, Dr LimorOpenNCT02983799
(UHN) NECO / NECA Phase II, Open label Study of the Poly(ADP-ribose) Polymerase Inhibitor Niraparib (MK 4827) in Recurrent Endometrial CancerJimenez, Dr WaldoOpenNCT03016338
(UHN) PHL-086A Phase 2 Study of XL184 (Cabozantinib) in Recurrent or Metastatic Endometrial CancerHirte, Dr HalOn holdNCT01815151
Download PDF